Biomedical Materials and Engineering Research Center,Wuhan University of Technology, China, 430070;
Biomedical Materials and Engineering Research Center,Wuhan University of Technology, China, 430070;
Biomedical Materials and Engineering Research Center,Wuhan University of Technology, China, 430070;
Biomedical Materials and Engineering Research Center,Wuhan University of Technology, China, 430070;
Biomedical Materials and Engineering Research Center,Wuhan University of Technology, China, 430070;
hydroxyapatite (HAP) nanoparticles; K562 cells; MTT assay; cell cycle;
机译:羟基磷灰石纳米颗粒对K562细胞的抑制作用
机译:不同抑制作用及羟基磷灰石纳米粒子对正常细胞和癌细胞的机理在体外(体外)中的 i>
机译:核-壳羟基磷灰石/镁纳米结构:不含表面活性剂的简便合成,表征及其对白血病癌细胞的体外细胞生存力研究(K562)
机译:羟基磷灰石纳米颗粒对K562细胞的抑制作用
机译:beta2整联蛋白(CD11a / CD18)在K562细胞中的表达。
机译:羟基磷灰石纳米粒子对正常细胞和癌细胞的体内和体外抑制作用及机制不同
机译:羟基磷灰石纳米粒子对常量细胞和体内癌细胞的不同抑制作用及机理